Human cytomegalovirus plasmid-based amplicon vector system for gene therapy

Genetic Vaccines and Therapy

Volumn 3, Issue , 2005, Pages

  Mahmood, Kutubuddin ^a   Prichard, Mark N ^a   Duke, Gregory M ^a   Kemble, George W ^a   Spaete, Richard R ^a  

^a MEDIMMUNE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; CIS ACTING ELEMENT; ENHANCED GREEN FLUORESCENT PROTEIN; IMMEDIATE EARLY PROTEIN; VIRUS DNA; VIRUS VECTOR;

AMPLICON; ANIMAL CELL; ARTICLE; CELL LINEAGE; DNA CLEAVAGE; DNA PACKAGING; DNA REPLICATION ORIGIN; FIBROBLAST; GENE IDENTIFICATION; GENE THERAPY; HELPER VIRUS; HEMATOPOIETIC CELL; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; NONHUMAN; ORTHOLOGY; PLASMID; PROMOTER REGION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STEM CELL; VIRAL GENE DELIVERY SYSTEM; VIRION; VIRUS GENOME; VIRUS REPLICATION;

EID: 16344370041     PISSN: 14790556     EISSN: None     Source Type: Journal    
DOI: 10.1186/1479-0556-3-1     Document Type: Article

References (71)

1. Anders DG, Kacica MA, Pari G, Punturieri SM: Boundaries and structure of human cytomegalovirus oriLyt, a complex origin for lytic-phase DNA replication. J Virol 1992, 66:3373-3384.
2. Anders DG, Punturieri SM: Multicomponent origin of cytomegalovirus lytic-phase DNA replication. J Virol 1991, 65:931-937.
3. Barnett JW, Eppstein DA, Chan HW: Class I defective herpes simplex virus DNA as a molecular cloning vehicle in eucaryotic cells. J Virol 1983, 48:384-95.
4. Bear SE, Colberg-Poley AM, Court DL, Carter BJ, Enquist LW: Analysis of two potential shuttle vectors containing herpes simplex virus defective DNA. J Mol Appl Genet 1984, 2:471-84.
5. Beck S, Barrell B: An HCMV reading frame which has similarity with both the V and C regions of the TCR gamma chain. DNA Seq 1991, 2:33-8.
6. Bolovan-Fritts CA, Mocarski ES, Wiedeman JA: Peripheral blood CD14(+) cells from healthy subjects carry a circular conformation of latent cytomegalovirus genome. Blood 1999, 93:394-8.
7. Borst EM, Messerle M: Construction of a cytomegalovirus-based amplicon: a vector with a unique transfer capacity. Hum Gene Ther 2003, 14:959-70.
8. Browne H, Smith GSB, Minson T: A complex between the MHC class I homologue encoded by human cytomegalovirus and beta 2 microglobulin. Nature 1990, 347:770-2.
9. Caux C, Favre C, Saeland S, Duvert V, Mannoni P, Durand I, Aubry JP, deVries JE: Sequential loss of CD34 and class II MHC antigens on purified cord blood hematopoietic progenitors cultured with IL-3: characterization of CD34-, HLA-DR+ cells. Blood 1989, 74:1287-94.
10. Chee MS, Bankier ATSB, Bohni R, Brown CM, Cerny R, Horsnell T, Hutchison CA III, Kouzarides T, Martignetti JA, Preddie E, Satchwell SC, Tomlinson P, Weston KM, Barrell BG: Analysis of the protein-coding content of the sequence of the human cytomegalovirus strain AD169. In Current Topics in Microbiology and Immunology Volume 154. Edited by: McDougall JK. Berlin: Springer-Verlag; 1990:125-169.
11. Chen Z, Sugano S, Watanabe S: A 189-bp repeat region within the human cytomegalovirus replication origin contains a sequence dispensable but irreplaceable with other sequences. Virology 1999, 258:240-248.
12. Chen Z, Watanabe S, Yamaguchi N: Strain-dependent differences in the human cytomegalovirus replication origin. Arch of Virology 1996, 141:13-30.
13. Cuifo DM, Hayward GS: Tandem repeat defective DNA from the L segment of the HSV genome. In Herpesvirus DNA Series Edited by: Becker Y. The Hague: Martinus Nijhoff; 1981:107-128.
14. de Wynter EA, Emmerson AJ, Testa NG: Properties of peripheral blood and cord blood stem cells. Baillierres Best Pract Res Clin Haematol 1999, 12:1-17.
15. Deiss LP, Frenkel N: Herpes simplex virus amplicon: cleavage of concatemeric DNA is linked to packaging and involves amplification of the terminally reiterated a sequence. J Virol 1986, 57:933-41.
16. Douglas JL, Lin WY, Panis ML, Veres G: Efficient human immunodeficiency virus-based vector transduction of unstimulated human mobilized peripheral blood CD34+ cells in the SCIDhu Thy/Liv model of human T cell lymphopoiesis. Hum Gene Ther 2001, 12:401-13.
17. Fraefel C, Song S, Lim F, Lang P, Yu L, Wang Y, Wild P, Geller AI: Helper virus-free transfer of herpes simplex virus type 1 plasmid vectors into neural cells. J Virol 1996, 70: 190-97.
18. Frenkel N, Locker H, Batterson W, Hayward GS, Roizman B: Anatomy of herpes simplex virus DNA. VI. Defective DNA originates from the S component. J Virol 1976, 20:527-31.
19. Gao JL, Murphy PM: Human cytomegalovirus open reading frame US28 encodes a functional beta chemokine receptor. J Biol Chem 1994, 269:28539-42.
20. Geller AI, Yu L, Wang Y, Fraefel C: Helper virus-free herpes simplex virus-1 plasmid vectors for gene therapy of Parkinson's disease and other neurological disorders. Exp Neurol 1997, 144:98-102.
21. Gentry T, Smith C: Retroviral vector-mediated gene transfer into umbilical cord blood CD34br, CD38-, CD33- cells. Exp Hematol Stem Cell Res 1999, 27(8):1244-54.
22. Goerner M, Roecklein B, Torok-Storb B, Heimfeld S, Kiem HP: Expansion and transduction of nonenriched human cord blood cells using HS-5 conditioned medium and FLT3-L. J Hematother Stem Cell Res 2000, 9:759-65.
23. Hahn G, Jores R, Mocarski ES: Cytomegalovirus remains latent in a common precursor of dendritic and myeloid cells. Proc Natl Acad Sci U S A 1998, 95:3937-42.
24. Hamzeh FM, Lietman PS, Gibson W, Hayward GS: Identification of the lytic origin of DNA replication in human cytomegalovirus by a novel approach utilizing ganciclovir-induced chain termination. J Virol 1990, 64:6184-6195.
25. Ho DY: Amplicon-based herpes simplex virus vectors. Methods Cell Biol 1994, 43:191-210.
26. Jacobs A, Breakfield XO, Fraefel C: HSV-1-based vectors for gene therapy of neurological diseases and brain tumors: part II. Vector systems and applications. Neoplasia 1999, 1: 02-416.
27. Kemble G, Duke G, Winter R, Spaete R: Defined large-scale alterations of the human cytomegalovirus genome constructed by cotransfection of overlapping cosmids. J Virol 1996, 70: 044-48
28. Kemble GW, Mocarski ES: A host cell protein binds to a highly conserved sequence element (pac-2) with the cytomegalovirus a sequence. J Virol 1989, 63:4715-28.
29. Kondo K, Kaneshima H, Mocarski ES: Human cytomegalovirus latent infection of granulocyte-macrophage progenitors. Proc Natl Acad Sci U S A 1994, 91:11879-83.
30. Kwong AD, Frenkel N: Biology of herpes simplex virus (HSV) defective viruses and development of the amplicon system. In "Viral Vectors" Academic Press, Inc; 1995:25-42.
31. Locker H, Frenkel N: Structure and origin of defective genomes contained in serially passaged herpes simplex type 1 (Justin). J Virol 1979, 29:1065-77.
32. Lockridge KM, Zhou SS, Kravitz RH, Johnson JL, Sawai ET, Blewett EL, Barry PA: Primate cytomegaloviruses encode and express an IL-10-like protein. Virology 2000, 268:272-80.
33. Luther-Wyrsch A, Costello E, Thali M, Buetti E, Nissen C, Surbek D, Holzgreve W, Gratwohl A, Tichelli A, Wodnar-Filipowicz A: Stable transduction with lentiviral vectors and amplification of immature hematopoietic progenitors from cord blood of preterm human fetuses. Hum Gene Ther 2001, 12:377-89.
34. Maciejewski JP, Bruening EE, Donahue RE, Mocarski ES, Young NS, St Jeor SC: Infection of hematopoietic progenitor cells by human cytomegalovirus. Blood 1992, 80:170-78.
35. Mahmood K, Tolba K, Federoff H, Rosenblatt JD: The role of HSV amplicon vectors in cancer gene therapy. Gene Therapy and Molecular Biology 1999, 4:209-219.
36. Maniatis T, Fritsch EF, Sambrook J: Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor; 1989.
37. Masse MJ, Karlin S, Schachtel GA, Mocarski ES: Human cytomegalovirus origin of DNA replication (oriLyt) resides within a highly complex repetitive region. Proceedings of the National Academy of Science USA 1992, 89:5246-5250.
38. Mendelson M, Monard S, Sissons P, Sinclair J: Detection of endogenous human cytomegalovirus in CD34+ bone marrow progenitors. J Gen Virol 1996, 77:3099-102.
39. Mocarski ES, Bonyhadi M, Salimi S, McCune JM, Kaneshima H: Human cytomegalovirus in a SCID-hu mouse: thymic epithelial cells are prominent targets of viral replication. Proc Natl Acad Sci U S A 1993, 90:104-8.
40. Mocarski ES, Liu AC, Spaete RR: Structure and variability of the a sequence in the genome of human cytomegalovirus (Towne strain). J Gen Virol 1987, 68:2223-30.
41. Mocarski ES, Roizman B: Site-specific inversion sequence of the herpes simplex virus genome: domain and structural features. Proc Natl Acad Sci U S A 1981, 78:7047-51.
42. Mocarski ES Jr, Courcelle CT: Cytomegaloviruses and Their Replication. In Virology Lippincott - Williams & Wilkins Publishers, Philadelphia; 2001.
43. Murray BK, Biswal N, Bookout JB, Lanford RE, Courtney RJ, Melnick JL: Cyclic appearance of defective interfering particles of herpes simplex virus and the concomitant accumulation of early polypeptide VP175. Intervirology 1975, 5:173-84.
44. Neote K, DiGregorio D, Mak JY, Horuk R, Schall TJ: Molecular cloning, functional expression, and signaling characteristics of a C-C chemokine receptor. Cell 1993, 72:415-25.
45. Pari GS, Anders DG: Eleven loci encoding trans-acting factors are required for transient complementation of human cytomegalovirus oriLyt-dependent DNA replication. J Virol 1993, 67:6979-88.
46. Penfold ME, Dairaghi DJ, Duke GM, Saederup N, Mocarski ES, Kemble GW, Schall TJ: Cytomegalovirus encodes a potent alpha chemokine. Proc Natl Acad Sci U S A 1999, 96:9839-44.
47. Ramirez ML, Virmani M, Garon C, Rosenthal LJ: Defective virions of human cytomegalovirus. Virology 1979, 96: 11-14.
48. Roizman B, Pellett PE: The Family Herpesviridae: A Brief Introduction. In Virology Lippincott - Williams & Wilkins Publishers, Philadelphia; 2001.
49. Romi H, Singer O, Rapaport D, Frenkel N: Tamplicon-7, a novel T-lymphotrpic vector derived from human herpesvirus 7. J Virol 1999, 73:7001-07.
50. Saederup N, Lin YC, Dairaghi DJ, Schall TJ, Mocarski ES: Cytomegalovirus- encoded beta chemokine promotes monocyte-associated viremia in the host. Proc Natl Acad Sci 1999, 96:10881-86.
51. Sanger F, Nicklen S, Coulson AR: DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A 1977, 74:5463-67.
52. Schroder CH, Stegmann B, Lauppe HF, Kaerner HC: An unusual defective genotype derived from herpes simplex virus strain ANG. Intervirology 1975, 6:270-84.
53. Sindre H, Tjoonnfjord GE, Rollag H, Ranneberg-Nilsen T, Veiby OP, Beck S, Degre M, Hestdal K: Human cytomegalovirus suppression of and latency in early hematopoietic progenitor cells. Blood 1996, 88:4526-33.
54. Slobedman B, Mocarski ES: Quantitative analysis of latent human cytomegalovirus. J Virol 1999, 73:4806-12.
55. Soderberg C, Larsson S, Bergstedt-Lindqvist S, Moller E: Definition of a subset of human peripheral blood mononuclear cells that are permissive to human cytomegalovirus infection. J Virol 1993, 67:3166-75.
56. Soderberg-Naucler C, Fish KN, Nelson JA: Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors. Cell 1997, 91:119-26.
57. Spaete RR, Frenkel N: The herpes simplex virus amplicon: A new eucaryotic defective-virus cloning-amplifying vector. Cell 1982, 30:295-304.
58. Spaete RR, Mocarski ES: The a sequence of the cytomegalovirus genome functions as a cleavage/packaging signal for herpes simplex virus defective genomes. J Virol 1985, 54: 17-824.
59. Stinski MF, Mocarski ES, Thomsen DR: DNA of human cytomegalovirus: size heterogeneity and defectiveness resulting from serial undiluted passage. J Virol 1979, 31:231-39.
60. Stow ND: Localization of an origin of DNA replication within the TRS/IRS repeated region of the herpes simplex virus type 1 genome. Embo J 1982, 1:863-7.
61. Stow ND, McMonagle EC: Characterization of the TRS/IRS origin of DNA replication of herpes simplex virus type 1 Virology 1983, 130:427-38.
62. Stow ND, McMonagle EC, Davison AJ: Fragments from both termini of the herpes simplex virus type 1 genome contain signals required for the encapsidation of viral DNA Nucleic Acids Res 1983, 11:8205-20.
63. Sun M, Zhang GR, Yang T, Yu L, Geller AI: Improved titers for helper virus-free herpes simplex virus type 1 plasmid vectors by optimization of the packaging protocol and addition of noninfectious herpes simplex virus-related particles (previral DNA replication enveloped particles) to the packaging procedure. Hum Gene Ther 1999, 10:2005-11.
64. Tamashiro JC, Filpula D, Friedmann T, Spector DH: Structure of the heterogeneous L-S junction region of human cytomegalovirus strain AD169 DNA. J Virol 1984, 52:541-48.
65. Tamashiro JC, Spector DH: Terminal structure and heterogeneity in human cytomegalovirus strain AD169. J Virol 1986, 59:591-604.
66. Vieira J, Schall TJ, Corey L, Geballe AP: Functional analysis of the human cytomegalovirus US28 gene by insertion mutagenesis with the green fluorescent protein gene. J Virol 1998, 72: 158-65.
67. Vlazny DA, Frenkel N: Replication of herpes simplex virus DNA: localization of replication recognition signals within defective virus genomes. Proc Natl Acad Sci USA 1981, 78:742-46.
68. von Laer D, Meyer-Koenig U, Serr A, Finke J, Kanz L, Fauser AA, Neumann-Haefelin D, Brugger W, Hufert FT: Detection of cytomegalovirus DNA in CD34+ cells from blood and bone marrow. Blood 1995, 86:4086-90.
69. Wagner MJ, Summers WC: Structure of the joint region and the termini of the DNA of herpes simplex virus type 1. J Virol 1978, 27:374-87.
70. Wang F, Seldin DC, Annis B, Trocha A, Johnson RP: Immune modulation of human B lymphocytes by gene transfer with recombinant Epstein-Barr virus amplicons. J Virol Methods 1998, 72: 1-93.
71. Wang S, Vos J-M: A hybrid herpesvirus infectious vector based on Epstein-Barr virus and herpes simplex virus type 1 for gene transfer into human cells in vitro and in vivo. J Virol 1996, 70:8422-8430.